Journal Information
Vol. 13. Issue 6.
Pages 775-787 (November - December 2007)
Share
Share
Download PDF
More article options
Vol. 13. Issue 6.
Pages 775-787 (November - December 2007)
Artigo Original / Original Article
Open Access
Tromboembolismo pulmonar e asma de difícil controlo
Pulmonary embolism and difficult-to-treat asthma
Visits
5024
Catarina Teles Martins1, Carlos Lopes2, Alda Manique3, Dolores Moniz3, Renato Sotto-Mayor3, A Bugalho de Almeida4
1 Interna do Internato Complementar de Pneumologia, Serviço de Pneumologia do Hospital de Santa Maria, Lisboa / Pulmonology Resident, Pulmonology Unit, Hospital de Santa Maria, Lisbon
2 Assistente de Pneumologia, Serviço de Pneumologia do Hospital de Santa Maria, Lisboa / Pulmonology Consultant, Pulmonology Unit, Hospital de Santa Maria, Lisbon
3 Assistente Graduada de Pneumologia, Serviço de Pneumologia do Hospital de Santa Maria, Lisboa / Specialist Consultant in Pulmonology, Pulmonology Unit, Hospital de Santa Maria, Lisbon
4 Chefe de Serviço de Pneumologia, Serviço de Pneumologia do Hospital de Santa Maria, Lisboa / Head, Pulmonology Unit, Pulmonology Unit, Hospital de Santa Maria, Lisbon
This item has received

Under a Creative Commons license
Article information
Resumo

O controlo da asma é um factor crucial na abordagem do doente: a mais recente actualização do GINA considera que uma “asma difícil de tratar” é uma asma para investigar. O não cumprimento da terapêutica, a DPOC concomitante, o tabagismo, a rinossinusite, o refluxo gastroesofágico e a obesidade são considerados os principais motivadores da asma difícil de controlar.

O presente trabalho teve por objectivo avaliar o papel do tromboembolismo pulmonar (TEP) na asma grave de difícil controlo.

Foram revistos os processos clínicos de doentes asmáticos da consulta de Alergologia Respiratória do nosso Serviço, entre 2004 e 2006, com asma “persistente grave” de acordo com o GINA 2005. Foram seleccionados os que, apesar de terapêutica optimizada, apresentavam asma “não controlada” (GINA 2006) e analisadas as suas causas. Dos 254 doentes estudados, 28 (11%) preenchiam os critérios de “asma persistente grave” (idade média 44±18 anos; 86% sexo feminino); destes, 57% (n=16) tinham doença “não controlada” – 35% (n=6) por má adesão à terapêutica; 29% (n=5) por TEP (confirmado gamagra-ficamente); 12% (n=2) por rinossinusite grave; 6% (n=1) por síndroma hipereosinofílica; 6% (n=1) por contacto mantido com alérgenos e 6% (n=1) em estudo.

Os doentes com TEP (idade média 56±9 anos; 80% sexo feminino; 80% raça branca) tiveram o diagnóstico de asma na idade adulta (média 37 anos), tendo decorrido cerca de 18 anos até ao diagnóstico de TEP. A análise dos factores predisponentes para TEP revelou: insuficiência venosa periférica (40%), HTA (40%) e deficiência de proteína C e S funcionais (20%).

Todos os doentes efectuaram terapêutica anticoagulante (80% ainda mantém), referindo-se que, após o início da anticoagulação, 40% dos doentes alcançaram o controlo da doença e 40% têm, actualmente, asma “parcialmente controlada”, não se tendo verificado novos internamentos por agudização da doença.

Os resultados do presente trabalho apoiam a inclusão do TEP no grupo de comorbilidades possivelmente responsáveis pelo mau controlo da asma.

Rev Port Pneumol 2007; XIII (6): 776-787

Palavras-chave:
Tromboembolismo pulmonar
asma grave
asma não controlada
Abstract

Asthma control is a key point in patient management. GINA’s most recent report emphasises the need to investigate uncontrolled asthma, of which non-com-pliance with treatment, COPD, smoking, chronic sinusitis, gastroesophageal reflux disease and obesity are the usual causes.

The aim of this work is to evaluate the role of pulmonary thromboembolism (PTE) in cases of difficult-to-treat asthma. We reviewed the case reports of patients with severe persistent asthma followed in our Asthma Outpatients Clinic between 2004 and 2006. We selected the ones that maintained uncontrolled disease despite an optimal therapeutical approach and investigated the causes.

In this group (n=254), 28 (11%) had severe persistent asthma and their mean age was 44±SD18 years old. 86% were females. Of these, 57% (n=16) had uncontrolled disease: 35% (n=6) due to non-compliance with treatment; 29% (n=5) pulmonary thrombombolism (scintigraphic confirmation); 12% (n=2) severe rhinosinusitis; 6% (n=1) hypereosinophilic syndrome; 6% (n=1) persistent allergen exposure and 6% (n=1) are still being investigated.

Patients with TPE (mean age 56±SD9 years old; 80% females; 80% Caucasians) were diagnosed with asthma as adults (mean age 37±SD14 years old). The mean time until the diagnosis of TPE was 18±SD12 years. Predisposing factors for TPE were venous insufficiency (40%), hypertension (40%) and deficit of functional protein C and S (20%).

All these patients received anticoagulant therapy (80% are still medicated). It should be noted that after the beginning of anticoagulants, 40% of the patients achieved control of their asthma and 40% have partially controlled disease. There were no hospital admissions for asthma exacerbations after the beginning of anticoagulation in this group.

This study supports the inclusion of TPE in the group of comorbidities to consider while investigating uncontrolled asthma.

Rev Port Pneumol 2007; XIII (6): 776-787

Key-words:
Pulmonary thromboembolism
severe asthma
difficult-to-treat asthma
Full text is only aviable in PDF
Bibliografia / Bibliography
[1.]
GINA Report WR 2006
[2.]
D.S. Robinson, et al.
Systematic assessment of difficult-to-treat asthma.
Eur Respir J, 22 (2003), pp. 478-483
[3.]
M. Masolini, et al.
The global burden of asthma: executive summary of the GINA dissemination committee report.
[4.]
S. Wenzel.
Severe asthma in adults.
Am J Crit Care Med, 172 (2005), pp. 149-160
[5.]
M.E. Strek.
Difficult asthma.
Proc Am Thorac Soc, 3 (2006), pp. 116-123
[6.]
Torbicki, et al.
Guidelines on diagnosis and management of acute pulmonary embolism.
Eur Heart Journal, 21 (2000), pp. 1301-1336
[7.]
P.D. Stein, et al.
Clinical, laboratory, roentgenographic and electrocardiographic signs in patients with acute pulmonary embolism and no pre-existing cardiac or pulmonary diseas.
Chest, 100 (1991), pp. 598-603
[8.]
Stanek Riedel, et al.
Long-term follow-up of patients with pulmonary thromboembolism. Late prognosis and evaluation of hemodynamic and respiratory data.
Chest, 81 (1982), pp. 151-158
[9.]
M. Hume, et al.
Venous thrombosis and pulmonary embolism.
pp. 206-207
[10.]
D.W. Barritt.
Clinical features of pulmonary embolism.
Lancet, 1 (1961), pp. 729-732
[11.]
Calvo Romero, et al.
Wheezing in patients with acute pulmonary embolism with and without previous cardiopulmonary disease.
Eur J Emergency Med, 10 (2003), pp. 288-289
[12.]
J.W. Severinghaus, et al.
Unilateral hypoventilation produced in dogs by occluding one pulmonary artery.
J Appl Physiol, 16 (1961), pp. 53-60
[13.]
E.W. Swenson, et al.
Unilateral hypoventilation in man during temporary occlusion of one pulmonary artery.
J Clin Invest, 40 (1961), pp. 828-835
[14.]
M. Perol, et al.
Bronchospasm disclosing pulmonary embolism.
Rev Pneumol Clin, 46 (1990), pp. 225-228
[15.]
V.M. Divekar, et al.
Pulmonary embolism during anaesthesia – case report.
Canad Anaesth Soc J, 28 (1981), pp. 277-279
[16.]
GINA Report WR 2005
Copyright © 2007. Sociedade Portuguesa de Pneumologia/SPP
Pulmonology
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?